logo

For the Inventor, By the Inventor

Ile Bizard, Canada

Dwight MacDonald

This inventor holds 6 USPTO granted patents. Top assignees: Merck Frosst Canada & Co., Merck Frosst Canada, Inc., Actelion Pharmaceuticals Ltd. Active years: 1993-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dwight MacDonald. Retrieved from https://idiyas.com/inventor/dwight-macdonald-tm4eymuv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 33.3

Average Co-Inventor Count = 8.1

ph-index = 2

Forward Citations = 32(Granted Patents)


Location History:

  • L'lle-Bizard, CA (2005)
  • L'Ile Bizard, CA (2006)
  • Ile Bizard, CA (1993 - 2011)
  • Kirkland, CA (2011)

Company Filing History:

goldMedal2 out of 80 
 
Merck Frosst Canada & Co.
 patents
silverMedal2 out of 212 
 
Merck Frosst Canada, Inc.
 patents
bronzeMedal1 out of 217 
 
Actelion Pharmaceuticals Ltd
 patents
4. 1 out of 40 
 
Merck Canada Inc.
 patents

Years Active: 1993-2011

Loading Chart...
6 patents (USPTO):Explore Patents
1. 8063105 - Renin inhibitors (2011-11-22),
2. 7968720 - Secondary amines as renin inhibitors (2011-06-28),
3. 7144896 - Hetero-bridge substituted 8-arylquinoline pde4 inhibitors (2006-12-05),
4. 6919353 - Substituted 8-arylquinolune PDE4 inhibitors (2005-07-19),
5. 6410563 - Substituted 8-arylquinoline phosphodiesterase-4 inhibitors (2002-06-25),
6. 5202321 - Thiopyrano[2,3,4-c,d]indoles as inhibitors of leukotriene biosynthesis (1993-04-13),

Title: Dwight MacDonald: Innovator in Renin Inhibitors

Introduction

Dwight MacDonald is a notable inventor based in Ile Bizard, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of renin inhibitors. With a total of 6 patents to his name, MacDonald has focused on innovative solutions for treating cardiovascular events and renal insufficiency.

Latest Patents

Among his latest patents, MacDonald has developed novel renin inhibitors that are characterized by a general Formula (I). These compounds serve as active ingredients in pharmaceutical compositions aimed at addressing cardiovascular issues and renal insufficiency. Additionally, he has created secondary amine derivatives of formula (I), which also function as renin inhibitors. These inventions include processes for the preparation of the compounds and their use in pharmaceutical formulations.

Career Highlights

Throughout his career, Dwight MacDonald has worked with prominent companies such as Merck Frosst Canada & Co. and Merck Frosst Canada, Inc. His work has significantly impacted the pharmaceutical industry, particularly in the area of cardiovascular and renal health.

Collaborations

MacDonald has collaborated with notable colleagues, including Daniel Dube and Michel Gallant. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Dwight MacDonald stands out as an influential inventor in the pharmaceutical field, particularly with his innovative work on renin inhibitors. His contributions continue to play a vital role in improving health outcomes for patients with cardiovascular and renal conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…